PLCB3 Antibody (Center) Blocking Peptide
€363.00
In stock
SKU
AC-BP2826c
Background:
The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes.
Other Names:
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3, Phosphoinositide phospholipase C-beta-3, Phospholipase C-beta-3, PLC-beta-3, PLCB3
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP2826c was selected from the Center region of human PLCB3. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: PLCB3 {ECO:0000312|EMBL:AAA77683.1}
Gene ID: 5331
Primary Accession: Q01970
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes.
Other Names:
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3, Phosphoinositide phospholipase C-beta-3, Phospholipase C-beta-3, PLC-beta-3, PLCB3
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP2826c was selected from the Center region of human PLCB3. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: PLCB3 {ECO:0000312|EMBL:AAA77683.1}
Gene ID: 5331
Primary Accession: Q01970
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review